BioSpace News Archive

Technavio has announced their latest drug pipeline analysis report on influenza A. The report includes a comprehensive research on the pipeline molecules under investigation by the pharmaceutical companies within the defined data collection period for the treatment of influenza A.

Orbis Education and Utica College welcomed the first cohort to the school’s new Accelerated Bachelor of Science in Nursing (ABSN)program in Miramar, Fla.

D2 Consulting (D2), (www.d2rx.com) a leading life sciences consulting firm that provides commercialization services to pharmaceutical, biotechnology and medical device companies as well as various accreditation and support services to specialty pharmacies today announced its participation at the NASP annual meeting and educational conference.

The Hyundai Hope On Wheels Foundation embarks on a nationwide tour this September in honor of National Childhood Cancer Awareness Month to award $14.1 million to 38 researchers, surpassing $145 million in total giving.

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received a milestone payment of $250,000 (USD) from Orphazyme A/S (CPH: ORPHA).

CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business served as administrative agent and lead arranger for $115 million first lien credit facility and sole lead arranger for a $29 million second lien credit facility on behalf of Bristol Hospice LLC to finance the acquisition of two additional hospice providers and provide ongoing working capital.

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Esmolol Hydrochloride in Sodium Chloride Injection, 2,500 mg/250 mL (10 mg/mL) Single-Dose Plastic Bag and 2,000 mg/100 mL (20 mg/mL) Single-Dose Plastic Bag, the first generic version of the reference listed drug, Baxter’s Brevibloc®.

Policy Extends Scope of Ongoing Efforts to Continue Meeting Customer Expectations for Chemical Management and Product Safety

Recognized as a sustainability leader in the Materials Industry category

LMG Life Sciences has named Fish & Richardson the 2018 General Patent Litigation Firm of the Year and the Intellectual Property Firm of the Year.